Voyager Therapeutics, Inc.
VYGR • NASDAQ
Voyager Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alfred W. Sandrock Jr., with a market cap of $236.0M.
CEOAlfred W. Sandrock Jr.
Next Earnings
Upcoming earnings announcement for Voyager Therapeutics, Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Revenue Estimate
$8.9M
Earnings History
Past 12 earnings reports for Voyager Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.46Est: -$0.52 | +11.5% | $15.3MEst: $10.2M | +50.7% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.47Est: -$0.52 | +9.6% | $13.4MEst: $8.1M | +64.6% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.57Est: -$0.51 | -11.8% | $5.2MEst: $10.4M | -49.8% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.53Est: -$0.44 | -20.5% | $6.5MEst: $13.6M | -52.2% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.59Est: -$0.35 | -68.6% | $6.3MEst: $16.6M | -62.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.16Est: -$0.45 | +64.4% | $24.6MEst: $11.9M | +107.1% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.18Est: -$0.41 | +56.1% | $29.6MEst: $9.5M | +212.7% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.20Est: -$0.44 | +54.5% | $19.5MEst: $9.4M | +107.4% | 10-Q |
| Feb 28, 2024 | Q4 2023 | $1.25Est: -$0.29 | +531.0% | $90.1MEst: $20.6M | +336.6% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.59Est: -$0.58 | -1.7% | $4.6MEst: $2.9M | +58.6% | — |
| Aug 3, 2023 | Q2 2023 | -$0.51Est: -$0.59 | +13.6% | $4.9MEst: $2.0M | +142.7% | 10-Q |
| May 9, 2023 | Q1 2023 | $2.94Est: $0.77 | +281.8% | $150.5MEst: $41.0M | +267.0% | — |